Switching to Faricimab Improves nAMD Dryness, Reduces Treatment Burden
New data from the Cleveland Clinic Cole Eye Institute showed patients not responding to anti-VEGF inhibitors could improve clinical and regimen parameters with short-term faricimab.
Source: hcplive.com